Curium US LLC

Curium is the world's leading radiopharmaceutical manufacturer and provider, delivering nuclear medicine solutions across diagnostic imaging and therapeutic applications. The company manufactures and distributes radiopharmaceuticals (SPECT and PET agents) used in oncology, cardiology, and neurology imaging. Curium operates a global network of 4 manufacturing facilities, 1 molybdenum-99 processing plant, 45+ radiopharmacies, and 6,000+ customer locations across 70+ countries, serving approximately 15 million patients annually. The company maintains 100+ years of combined industry heritage and operates multiple regional headquarters and manufacturing centers including facilities in Maryland Heights (MO) and Noblesville (IN) in the United States, as well as production sites in Finland, the Netherlands, France, and Austria. Curium's portfolio includes 50+ radiopharmaceutical products for PET and SPECT imaging. The organization employs 5,000+ skilled professionals and maintains a commitment to quality, innovation, and service reliability. Regulatory compliance and manufacturing standards align with international requirements for pharmaceutical and medical device production in nuclear medicine.